| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2576800 | International Congress Series | 2006 | 6 Pages |
Abstract
Most therapeutic considerations with regard to cardiovascular disease are the same in Turner syndrome (TS) as in the general population with similar problems. However, precious little is known about the unique risks for aortic root enlargement and dissection in TS that would potentially alter treatment decisions. This article highlights the issues related to the medical, surgical and catheter-based approaches to the treatment of congenital heart disease in TS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
Michael Silberbach,